Eye gaze and pupillary response in Angelman syndrome.
Michael P Hong, Janna L Guilfoyle, Lindsey N Mooney and 5 others
PMID 28750207WHAT IT FOUND
Only 8 of 17 people with Angelman syndrome completed eye tracking.
Those who did looked less at social scenes than typically developing controls and showed no pupil difference between social and geometric scenes. This is not yet a clinical test.
Key findings
01Eight of seventeen individuals with Angelman syndrome completed the eye tracking paradigm, with 47% evaluable data; failed calibration and physical limitations were common reasons.
02Among participants who completed eye tracking, Angelman syndrome showed lower social scene preference than typically developing controls and did not statistically differ from autism spectrum disorder controls.
03Angelman syndrome showed no pupil difference between social and geometric scenes compared with typically developing controls, while autism spectrum disorder did not statistically differ from either group.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only 8 of 17 participants with Angelman syndrome provided evaluable eye tracking data, so the results may not represent the broader Angelman syndrome population. The control groups were selected retrospectively from earlier studies, which may introduce selection differences. No eye exam or visual acuity test was included, and strabismus is common in Angelman syndrome, so visual factors could affect gaze and pupil results. The social and geometric video clips were not matched for contrast, luminance, and motion, so low-level visual features may have influenced preference. The Angelman syndrome group had severe intellectual disability, which can create a floor effect on eye tracking and behavioral measures. The autism spectrum disorder group showed wide variability in pupil response, which may explain why it did not statistically differ from either group. The study did not test whether eye tracking improves diagnosis, guides therapy, or explains mechanisms.
The easy way to misread this
Do not conclude that eye tracking is ready for routine clinical assessment of Angelman syndrome. Only 8 of 17 participants completed it, and the study did not test whether these gaze or pupil measures improve diagnosis or guide therapy.